Women of childbearing potential must be enrolled in the UK Pregnancy Prevention Programme, use highly effective contraception, and complete annual counselling before and during treatment
MK-677 (Ibutamoren) Super-Responder Profile: Who Gets the Best Results and Why MK-677 (Ibutamoren) Profile of Super-Responders: Who Gets the Best Results At a glance Drug class / oral ghrelin-receptor agonist (growth hormone secretagogue) Typical clinical dose / 10 to 25 mg orally once daily at bedtime Peak IGF-1 response window / 4 to 12 weeks of continuous use Super-responder IGF-1 threshold / greater than 60% rise from baseline Key predictor 1 / low baseline IGF-1 (below 150 ng/mL in adults) Key predictor 2 / age under 40, especially under 30 Key predictor 3 / consistent dosing with high-protein diet (1.6+ g/kg/day) Main risk in super-responders / water retention, transient insulin resistance Regulatory status / not FDA-approved
Scientific Insights: What Research Says About GLP-1 and Hair Loss While anecdotal evidence highlights the possibility of hair loss associated with GLP-1 medications, scientific research in this area is still evolving
It does not carry oral, drops, or microdose compounded options, and does not stock Ozempic or Mounjaro
Ritschka, B
For best results, place the sheet mask on clean skin, leave on for 15-20 minutes, then gently pat residual essence until fully absorbed.
